Carmen Fajardo - Concepedia

Author

Carmen Fajardo

Also Known As

C FAJARDO, C Fajardo, C Fajardo Montañana, C. Fajardo, C. Fajardo Montañana, C. Fajardo-Montañana, Carmen Fajardo, Carmen Fajardo Montanana, Carmen Fajardo Montañana, Carmen Fajardo Montañana

164

Publications

Citations

H-Index

Concepts

All Affiliations

Hospital de La Ribera Centre for Biomedical Network Research on Rare Diseases Hospital Universitari i Politècnic La Fe Hospital General Universitario de Alicante Doctor Balmis Universitat Autònoma de Barcelona

About

Carmen Fajardo is an author at Hospital de La Ribera specializing in medicine, pathology, and diabetes.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	13	4.5K
2	Diabetes	5	5	4.1K
3	Public Health	2	2	2.8K
4	Endocrinology	2	2	183
5	Cell Biology	1	1	61

Carmen Fajardo

Publications

6.4K

Citations

H-Index

Page 1

	Year	Citations
Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseHealth PolicyCardiovascular Outcomes	2019	2.8K
Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais, The Lancet Metabolic SyndromeDiabetes ManagementUrologyChronic Kidney DiseaseDiabetes	2019	600
Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial Stefano Del Prato, Steven E. Kahn, Imre Pávó, The Lancet Metabolic SyndromeDiabetes ManagementCardiovascular DiseaseMedicineInsulin Management	2021	586
Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line<i>AIP</i>Mutations and Pituitary Adenomas: An International Collaborative Study Adrian Daly, María A. Tichomirowa, Patrick Pétrossians, The Journal of Clinical Endocrinology & Metabolism	2010	361
Aryl Hydrocarbon Receptor-Interacting Protein Gene Mutations in Familial Isolated Pituitary Adenomas: Analysis in 73 Families Adrian F. Daly, Jean-François Vanbellinghen, Sok Kean Khoo, The Journal of Clinical Endocrinology & Metabolism	2007	320
Acromegaly at diagnosis in 3173 patients from the Liège Acromegaly Survey (LAS) Database Patrick Pétrossians, Adrian Daly, Luigi Maione, Endocrine Related Cancer	2017	237
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas María A. Tichomirowa, Anne Barlier, Adrian Daly, European Journal of Endocrinology	2011	167
Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial André Lacroix, Feng Gu, Wilson Gallardo, The Lancet Diabetes & Endocrinology Month Clinical TrialUrologyPituitary DiseaseAdrenal DiseaseEndocrinology	2017	163
Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications Marie‐Lise Jaffrain‐Rea, M. Angelini, D. Gargano, Endocrine Related Cancer	2009	144
Metabolic effects of pioglitazone in combination with insulin in patients with type 2 diabetes mellitus whose disease is not adequately controlled with insulin therapy: Results of a six-month, randomized, double-blind, prospective, multicenter, parallel-group study Vinod Mattoo, D.J.A. Eckland, Mario Widel, Clinical Therapeutics ObesityMetabolic SyndromeDiabetes ManagementMedicineInsulin Management	2005	93

Page 1